Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kariyone, A.
Right arrow Articles by Takatsu, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kariyone, A.
Right arrow Articles by Takatsu, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 15, No. 10, pp. 1183-1194, October 2003
© 2003 Japanese Society for Immunology

Immunogenicity of Peptide-25 of Ag85B in Th1 development: role of IFN-{gamma}

Ai Kariyone1, Toshiki Tamura1, Hideyuki Kano1, Yoichiro Iwakura2, Kiyoshi Takeda3, Shizuo Akira3 and Kiyoshi Takatsu1

1 Division of Immunology, Department of Microbiology and Immunology, and 2 Laboratory of Cell Biology, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan 3 Institute of Microbial Diseases, Osaka University, Osaka 565-0871, Japan

Correspondence to: K. Takatsu; E-mail, takatsuk{at}ims.u-tokyo.ac.jp
Transmitting editor: S. Koyasu

Ag85B (also known as {alpha} antigen or MPT59) is immunogenic, and induces expansion and differentiation of TCRVß11+CD4+ T cells to IFN-{gamma}-producing cells in C57BL/6 (I-Ab) mice. We reported that Peptide-25 (amino acids 240–254) of Ag85B is a major T cell epitope, and its amino acid residues at position 244, 247, 249 and 252 are I-Ab contact residues. Here we examined roles of IFN-{gamma} in the generation of Peptide-25-reactive CD4+ TCRVß11+ T cells and the efficacy of mutant peptides of Peptide-25 for Th1 development in mice other than C57BL/6 mice. Immunization of C57BL/6 mice with Peptide-25 included in incomplete Freund’s adjuvant led to preferential induction of CD4+ TCRVß11+ IFN-{gamma}- and tumor necrosis factor-{alpha}-producing T cells. Compared with other I-Ab-binding peptides such as Peptide-9 of Ag85B, 50V of pigeon cytochrome c and ovalbumin (OVA)265–280 peptide, only Peptide-25 was capable of inducing enormous expansion of TCRVß11+ IFN-{gamma}-producing T cells. Treatment of C57BL/6 mice with anti-Vß11 antibody before Peptide-25 immunization reduced the development of CD4+ IFN-{gamma}-producing T cells. Furthermore, B10.A(3R) mice, I-Ab-positive and TCRVß11– strain, showed remarkably lower response to Peptide-25 immunization than C57BL/6 mice. Peptide-25-primed IFN-{gamma}–/– cells showed significantly decreased expansion of CD4+ TCRVß11+ T cells as compared with wild-type cells. Interestingly, Peptide-25-primed cells from MyD88-deficient mice responded to Peptide-25 and differentiated into IFN-{gamma}-producing cells to a similar extent as wild-type mice, indicating Toll-like receptor-independent IFN-{gamma} production. These results imply that IFN-{gamma} plays important roles for the generation and expansion of CD4+ TCRVß11+ T cells in response to Peptide-25. Although Peptide-25 was non-immunogenic in C3H/HeN mice, a substituted mutant of Peptide-25, 244D247V, capable of binding to I-Ak, induced Th1 development. These results clearly demonstrate important roles of IFN-{gamma} in the expansion of CD4+ TCRVß11+ T cells, and will provide useful information for delineating the regulatory mechanisms of Th1-cell development and for analyzing mechanisms on Th1-dominant immune responses.

Keywords: Ag85B, mycobacterium, subunit vaccine, TCRVß11, tuberculosis


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
C. S. Andersen, J. Dietrich, E. M. Agger, N. Y. Lycke, K. Lovgren, and P. Andersen
The Combined CTA1-DD/ISCOMs Vector Is an Effective Intranasal Adjuvant for Boosting Prior Mycobacterium bovis BCG Immunity to Mycobacterium tuberculosis
Infect. Immun., January 1, 2007; 75(1): 408 - 416.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Nambu, S. Nakae, and Y. Iwakura
IL-1{beta}, but not IL-1{alpha}, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses
Int. Immunol., May 1, 2006; 18(5): 701 - 712.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Takamura, K. Matsuo, Y. Takebe, and Y. Yasutomi
Ag85B of Mycobacteria Elicits Effective CTL Responses through Activation of Robust Th1 Immunity as a Novel Adjuvant in DNA Vaccine
J. Immunol., August 15, 2005; 175(4): 2541 - 2547.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
T. Tamura, H. Ariga, T. Kinashi, S. Uehara, T. Kikuchi, M. Nakada, T. Tokunaga, W. Xu, A. Kariyone, T. Saito, et al.
The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model
Int. Immunol., December 1, 2004; 16(12): 1691 - 1699.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.